FERRARI, Marisa
 Distribuzione geografica
Continente #
NA - Nord America 3.083
AS - Asia 2.381
EU - Europa 2.134
SA - Sud America 338
AF - Africa 116
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.058
Nazione #
US - Stati Uniti d'America 3.002
CN - Cina 975
SG - Singapore 916
FI - Finlandia 512
DE - Germania 372
IE - Irlanda 352
UA - Ucraina 289
SE - Svezia 280
BR - Brasile 270
HK - Hong Kong 185
VN - Vietnam 129
NL - Olanda 85
ZA - Sudafrica 73
TR - Turchia 71
IT - Italia 65
CA - Canada 56
GB - Regno Unito 48
AR - Argentina 31
RU - Federazione Russa 29
BE - Belgio 27
CI - Costa d'Avorio 21
FR - Francia 21
BD - Bangladesh 20
IN - India 16
IQ - Iraq 15
MX - Messico 14
PL - Polonia 11
CZ - Repubblica Ceca 10
ES - Italia 8
CL - Cile 7
PY - Paraguay 7
VE - Venezuela 7
EC - Ecuador 6
ID - Indonesia 6
IR - Iran 6
JP - Giappone 6
KR - Corea 6
EG - Egitto 5
KE - Kenya 5
LT - Lituania 5
MD - Moldavia 5
TN - Tunisia 5
AT - Austria 4
PK - Pakistan 4
UZ - Uzbekistan 4
CO - Colombia 3
JO - Giordania 3
MA - Marocco 3
PE - Perù 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
EU - Europa 2
GA - Gabon 2
HN - Honduras 2
KZ - Kazakistan 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
NP - Nepal 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
TH - Thailandia 1
Totale 8.058
Città #
Singapore 463
Chandler 366
Dublin 352
Jacksonville 333
Santa Clara 246
Ashburn 234
Beijing 234
Hong Kong 183
Dearborn 173
Ann Arbor 151
Nanjing 138
Dallas 130
Munich 129
Boardman 121
Wilmington 94
Helsinki 86
Princeton 71
New York 69
San Mateo 69
Bremen 67
Johannesburg 66
Seattle 59
Izmir 58
Los Angeles 56
Ho Chi Minh City 48
Shenyang 47
Jinan 46
Shanghai 43
Toronto 43
Nanchang 41
Kunming 37
Hebei 34
Hanoi 33
Brussels 27
Council Bluffs 27
Parma 27
São Paulo 26
Buffalo 25
Hangzhou 23
Hefei 23
Moscow 23
Abidjan 21
Tianjin 21
Changsha 20
Des Moines 17
Jiaxing 17
Falkenstein 15
Columbus 14
Zhengzhou 14
Guangzhou 13
Woodbridge 13
The Dalles 12
Lanzhou 11
Rio de Janeiro 11
San Jose 11
Augusta 10
Haikou 10
Turku 10
Kocaeli 8
Monmouth Junction 8
Stockholm 8
Taiyuan 8
Warsaw 8
Atlanta 7
Belo Horizonte 7
Brno 7
Changchun 7
Chicago 7
Fremont 7
Haiphong 7
Houston 7
Montreal 7
Redwood City 7
Taizhou 7
Brooklyn 6
Jyväskylä 6
London 6
Milan 6
Orem 6
Tokyo 6
Auburn Hills 5
Chengdu 5
Denver 5
Goiânia 5
Hải Dương 5
Jakarta 5
Nairobi 5
Ningbo 5
Norwalk 5
Padova 5
San Francisco 5
Amsterdam 4
Ankara 4
Da Nang 4
Dhaka 4
Frankfurt am Main 4
Grafing 4
Juiz de Fora 4
Leawood 4
Ottawa 4
Totale 5.005
Nome #
2,6-Diacetylpyridine bis(thiosemicarbazones) zinc complexes: synthesis, structure, and biological activity 289
Biological insight into the mechanism of action of thiosemicarbazone complexes. 177
Bis(citronellalthiosemicarbazonato)nickel(II): tracking its pathways in histiocytic lymphoma U937 cells 158
Investigations on the apoptotic mechanisms induced by thiosemicarbazone metal-complexes. 158
Copper(II) and Cobalt(III) Pyridoxal Thiosemicarbazone Complexes with Nitroprusside as Counterion: Syntheses, Electronic Properties, and Antileukemic Activity 154
Metal complexes of retinoid derivatives with antiproliferative activity: synthesis, characterization and DNA interaction studies 146
Biological studies on the activity of copper(II) citronellalthiosemicarbazonates 145
Copper(II) and Nickel(II) thiosemicarbazone metal complexes: synthesis, characterization and biological interactions 144
Biotoxicological profile of some thiosemicarbazone metal complexes. 143
Synthesis, structural characterization and antiproliferative and toxic bio-activities of copper(II) and nickel(II) citronellal N4-ethylmorpholine thiosemicarbazonates 142
Synthesis, characterization and deepening in the comprehension of the biological action mechanisms of a new nickel complex with antiproliferative activity 137
Investigations into bis(triphenylphosphine)copper(I) complexes with cyclic derivatives of methylpyruvate thiosemicarbazones 137
Synthesis, characterization, crystal structure and luminescence properties of phosphinic silver(I) complexes with thiourea derivatives 136
Copper and nickel thiosemicarbazone complexes: synthesis, characterization and studies on their biological properties 136
Bis(tpp)copper(I) thiosemicarbazonates: unexpected chemistry revealed by X-ray diffration. 133
Cu(II) Complexes with Heterocyclic Substituted Thiosemicarbazones: The Case of 5-Formyluracil. Synthesis, Characterization, X-ray Structures, DNA Interaction Studies, and Biological Activity 131
Bis(triphenylphosphine)4-fluorobenzaldehyde thiosemicarbazone copper(I): Forcing chelation through oxoanions 131
Bis(tpp)copper(I) thiosemicarbazonates: Unexpected chemistry revealed by X-ray diffraction 131
CHEMICAL STUDIES OF THE BEHAVIOUR OF THIOSEMICARBAZONES AS LIGANDS IN COMPLEXES OF CU(I) STABILIZED BY TRIPHENYLPHOSPHINE 129
THIOSEMICARBAZONES DERIVATIVES (TSCD) EFFECTS ON HIV, HTLV-1 AND HTLV-2 INFECTED CELLS 129
Copper(II) Complexes with Chiral Diaminodiamido Ligands: Solution and Structural Studies 126
Synthesis, characterization, crystal structure and antiproliferative in vitro activity of long-chain aliphatic thiosemicarbazones and their Ni(II) complexes 122
Synthesis, characterization and antiproliferative and toxic bio-activities of copper and nickel citronellal ethylmorpholine thiosemicarbazonates 121
Synthesis, characterization and biological activity of Ni, Cu and Zn complexes of isatin hydrazones 120
Complex of 2-thiophenecarbonyl and isonicotinoyl hydrazones of 3-(N-methyl)isatin. A study of their antimicrobial activity 119
Cu(II) complexes with substituted thiosemicarbazones of alpha-ketoglutaric acid. Synthesis, X-ray structures, DNA binding studies, nuclease and biological activity 119
Studies on p-fluorobenzaldehyde thiosemicarbazones 118
Synthesis, characterization and crystal structure of triphenylphosphine copper(I) methylpyruvate thiosemicarbazones 117
Copper(II) Complexes with Chiral Diaminodiamido Ligands: Solution and Structural Studies 116
Cobalt(III) complexes with thiosemicarbazones as co-ordinating agents. Spontaneous resolution by crystallization and absolute configuration 116
New insights on the biological activity of [Ni(S-tcitr)2] 115
Crystal and molecular structure of [Ru(bpy)2(2,3-dpp)]Cl2.3H2O.CH3CN and 1H and 99Ru NMR spectra of [Ru(bpy)2(2,n-dpp)][PF6] (bpy=2,2'-bipyridine, dpp=bis(2-pyridyl)pyrazine,n=3 or 5) 114
Influence of substitution on citronellal thiosemicarbazone on the biological activity of its complexes. 113
Transition-Metal Complexes of Isatin-beta-Thiosemicarbazone. X-Ray Crystal Structure of Two Nickel Complexes 113
Synthesis, characterization and biological activity of copper complexes with pyridoxal thiosemicarbazone derivatives. X-ray crystal structure of three dimeric complexes. 113
Synthesis, characterization and X-ray structures of new antiproliferative and proapoptotic natural aldehyde thiosemicarbazones and their nickel(II) and copper(II) complexes 111
Synthesis, solution chemistry, x-ray structure and biological activity of novel pyridoxal thiosemicarbazone derivatives 111
Heterocyclic substituted thiosemicarbazones and their Cu(II) complexes: Synthesis, characterization and studies of substituents effects on coordination and DNA binding 110
Synthesis and characterization of square planar nickel(II) complexes with p-fluorobenzaldehyde thiosemicarbazone derivatives 109
Synthesis, characterization and biological activity of two new polymeric copper(II) complexes with alpha-ketoglutaric acid thiosemicarbazone 109
Preparation, characterization and X-ray structures of 1-methylisatin 3-thiosemicarbazone copper, nickel and cobalt complexes 108
Deepening in the comprehension of the action mechanisms of a new metal-based antiproliferative drug with DNA damaging action 106
New methyl pyruvate thiosemicarbazones and their copper and zinc complexes: synthesis, characterization, X-ray structures and biological activity 103
2,6-Diacetylpyridine Bis(Thiosemicarbazones) Zinc Complexes: Synthesis, Structure, and Biological Activity 102
Synthesis and functionalization of chiral superstructured porphyrins 101
NATURAL ALDEHYDE THIOSEMICARBAZONES AND THEIR NICKEL COMPLEXES: SYNTHESIS, CHARACTERIZATION AND STUDIES ON THEIR BIOLOGICAL PROPERTIES 100
Zinc complexes with cyclic derivatives of alpha-ketoglutaric acid thiosemicarbazone: synthesis, X-ray structures and DNA interactions 100
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine 99
NATURAL ALDEHYDE THIOSEMICARBAZONES AND THEIR NICKEL COMPLEXES: SYNTHESIS, CHARACTERIZATION AND STUDIES ON THEIR BIOLOGICAL PROPERTIES. 98
Isatin 3-semicarbazone and 1-methyl-isatin 3-semicarbazone 97
Synthesis, characterisation, X-ray structure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 97
Synthesis, spectroscopic and structural characterization, and biological activity of aquachloro(pyridoxal thiosemicarbazone) copper(II) chloride 94
Versatile chelating behavior of aliphatic thiosemicarbazones in zinc and cobalt complexes 91
Synthesis and characterization of potential metal based drugs and deepening in the comprehension of the action mechanisms 90
Sodium 2-oxo-3-semicarbazono-2,3-dihydro-1H-indole-5-sulfonate dihydrate 90
X-ray crystal and molecular structure of [3,6-bis(2-pyridyl)pyridazine-N1,N2]bis(triphenylphosphine)copper(I) hexafluorophosphate. 89
Synthetic, spectroscopic and X-ray crystallographic studies on copper(II) complexes with pyruvic acid and pyridoxal thiosemicarbazones. 88
Long-chain aliphatic thiosemicarbazones and their Ni(II)complexes. 88
Synthesis, spectroscopic and structural characterization of chlorobis(methyl pyruvate thiosemicarbazone)copper(I) and chlorobis(triphenylphosphine) (methyl pyruvate thiosemicarbazone) copper(I) toluene solvate (2/1) 85
Synthesis and structural characterization of chloro- bis(triphenylphosphine)(dithiooxamide)copper(I) 84
Total Synthesis of Both Enantiomers of trans-beta-Hydroxypipecolic Acid 83
μ-1,2,4,5-Tetrazine-N1:N4-bis(pentaammineruthenium) Tetracation: Synthesis and X-ray Structure 80
Synthesis and x-ray structures of dinitrato-bis[2-(2’-thienyl)-1-(2’-thienylmethyl)benzimidazole]copper(II) and dichloro-bis-[2-(2’-thienyl)-benzimidazole ]copper(II)-ethanol 78
Synthesis, structural characterization and biological activity of p-fluorobenzaldehyde thiosemicarbazones and of a nickel complex 78
Thiosemicarbazones as co-ordinating agents. Part 5.1 Zinc complexes derived from methyl pyruvate- and pyridoxal thiosemicarbazone 77
Synthesis Characterization and Biological Activity of Three Copper(II) Complexes with a Modified Nitrogenous Base: 5-Formyluracil Thiosemicarbazone 76
Synthesis and structural characterization of chloro-(triphenylphosphine)-[1-phenyl-3-(2-pyridyl)-2-thiourea ]Cu(I) and chloro-bis[1-phenyl-3-(2-pyridyl)-2-thiourea]Cu(I) 74
Synthesis, spectroscopic and structural characterization of methyl pyruvate- and pyridoxal-hydrazinopyruvoylthiosemicarbazones 73
Structure of dinitratobis(triphenylphosphine oxide)copper(II) toluene solvate (1/1) 71
Larger cyclophanes: Synthesis and structural characterization of [2.2.2.]paracyclophane compounds with SbBr3 and BiBr3 70
Total synthesis of both enantiomers of trans-β-hydroxypipecolic acid 68
Thiosemicarbazones as co-ordinating agents. Part 3. Synthesis, spectroscopic characterization, and X-ray structure of methyl piruvate thiosemicarbazone hemihydrate, chloro(ethyl pyruvate thiosemicarbazonato)copper(II) (green form), and chloro(pyruvic acid thiosemicarbazonato)copper(II) dihydrate (blue form) 65
Totale 8.101
Categoria #
all - tutte 28.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021361 0 0 0 0 0 10 64 2 146 14 118 7
2021/2022313 4 2 3 5 14 6 36 62 15 33 35 98
2022/20231.366 128 111 87 113 168 168 2 69 458 8 29 25
2023/2024426 30 57 7 12 33 137 18 41 12 20 32 27
2024/20251.531 34 78 93 110 125 243 72 107 158 124 102 285
2025/20261.820 278 267 379 260 472 164 0 0 0 0 0 0
Totale 8.101